Dibutyryl cyclic AMP-induced enhancement of tissue inhibitor of metalloproteinases-3 expression and its possible relation to the invasive activity of the human hepatoma cell line PLC/PRF/5

Anticancer Research

Volumn 19, Issue 6 B, 1999, Pages 5175-5180

  Okamoto, Yasuyuki ^a   Nakano, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Extracellular matrix; Gene expression; Growth inhibition; Matrigel; Polymerase chain reaction

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BUCLADESINE; CELL PROTEIN; GELATINASE A; GELATINASE B; MATRIGEL; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; METASTASIS; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; BUCLADESINE; CARCINOMA, HEPATOCELLULAR; DNA PRIMERS; HUMANS; LIVER NEOPLASMS; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TUMOR CELLS, CULTURED;

EID: 0033397031     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Van-Wijk R, Wicks WD and Clay K: Effects of derivatives of cyclic 3′,5′-adenosine monophosphate on the growth, morphology, and gene expression of hepatoma cells in culture. Cancer Res 32: 1905-1911, 1972.
2. Cho ChungYS, Clair T, Bodwin JS and Berghoffer B: Growth arrest and morphological change of human breast cancer cells by dibutyryl cyclic AMP and L-arginine. Science 214: 77-79, 1981.
3. Giuffre L, Schreyer M, Mach JP and Carrel S: Cyclic AMP induces differentiation in vitro of human melanoma cells. Cancer 61: 1132-1141, 1988.
4. Loesberg C, van Wijk R, Zandbergen J, van-Aken WG, van Mourik JA and de Groot PG: Cell cycle-dependent inhibition of human vascular smooth muscle cell proliferation by prostaglandin Exp Cell Res 160: 117-125, 1985.
5. Tortora G, Budillon A, Yokozaki H, Clair T, Pepe S, Merlo G, Rohlff C and Cho-Chung YS: Retroviral vector-mediated overexpression of the RII beta subunit of the cAMP-dependent protein kinase induces differentiation in human leukemia cells and reverts the transformed phenotype of mouse fibroblasts. Cell Growth Differ 5: 753-759, 1994.
6. Katsaros D, Tortora G, Tagliaferri P, Clair T, Ally S, Neckers L, Robins RK and Cho Chung YS: Site-selective cyclicAMP analogs provide a new approach in the control of cancercell growth. FEBS Lett 223: 97-103, 1987.
7. Ally S, Tortora G, Clair T, Grieco D, Merlo G, Katsaros D, Ogreid D, Doskeland SO, Jahnsen T and Cho-Chung YS: Selective modulation of protein kinase isozymes by the site-selective analog 8-chloroadenosine 3′,5′-cyclic monophosphate provides a biological means for control of human colon cancer cell growth. Proc Natl Acad Sci USA 85: 6319-6322, 1988.
8. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ and Sturgill TW: Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262: 1065-1069, 1993.
9. Cook SJ and McCormick F: Inhibition by cAMP of Ras-dependent activation of Raf. Science 262: 1069-1072, 1993.
10. Suh BS, Eisenbach L and Amsterdam A: Adenosine 3′,5′-monophosphate suppresses metastatic spread in nude mice of steroidogenic rat granulosa cells transformed by simian virus-40 and Ha-ras oncogene. Endocrinologyl 31: 526-532, 1992.
11. Zaizen Y, Taniguchi S, Noguchi S and Suita S: The effect of N-myc amplification and expression on invasiveness of neuroblastoma cells. J Pediatr Surg 28: 766-769, 1993.
12. Tanaka K, Iwamoto Y, Ito Y, Ishibashi T, Nakabeppu Y, Sekiguchi M and Sugioka Y: Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080. Cancer Res 55: 2927-2935, 1995.
13. Ura H, Bonfil RD, Reich R, Reddel R, Pfeifer A, Harris CC and Klein- Szanto AJ: Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res 49: 4615-4621, 1989.
14. Kubota S, Mitsudomi T and Yamada Y: Invasive human fibrosarcoma DNA mediated induction of a 92 kDa gelatinase/type IV collagenase leads to an invasive phenotype. Biochem Biophys Res Commun 181: 1539-1547, 1991.
15. Garbisa S, Scagliotti G, Masiero L, Di-Francesco C, Caenazzo C, Onisto M, Micela M, Stetler-Stevenson WG and Liotta LA: Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy. Cancer Res 52: 4548-4549, 1992.
16. Khokha R and Denhardt DT: Matrix metalloproteinases and tissue inhibitor of metalloproteinases: a review of their role in tumorigenesis and tissue invasion. Invasion Metastasis 9: 391-405, 1989.
17. Okamoto Y, Kikukawa M and Nakano H: Involvement of retinoblastoma protein in dibutyryl cyclic AMP-induced growth inhibition of the human hepatoma cells PLC/PRF/5. Int Hepatol Commun 5: 331-338, 1996.
18. Kikukawa M, Okamoto Y, Fukui H and Nakano H: Effect of dibutyryl cyclic AMP on the cyclin-dependent kinase inhibitor p27Kip1 in the human hepatoma cells PLC/PRF/5. Anticancer Res 17: 3287-3291, 1997.
19. Matsumoto M, Nakayama M, Kitagami K, Fukui H, Tsujii T, Okamoto Y and Nakano H: Effect of dibutyryl cyclic AMP in the treatment of hepatocellular carcinoma-intraarterial infusion therapy combined with anticancer agent for hepatocellular carcinoma with portal vein thrombosis. Gan To Kagaku Ryoho 19: 83-88, 1992.
20. Macnab GM, Alexander JJ, Lecatsas G, Bey EM and Urbanowicz JM: Hepatitis B surface antigen produced by a human hepatoma cell line. Br J Cancer 34: 509-515, 1976.
21. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
22. Arii S, Mise M, Harada T, Furutani M, Ishigami S, Niwano M, Mizumoto M, Fukumoto M and Imamura M: Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential. Hepatology 24: 316-322, 1996.
23. Leco KJ, Khokha R, Pavloff N, Hawkes SP and Edwards DR: Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 269: 9352-9360, 1994.
24. Silbinger SM, Jacobsen VL, Cupples RL and Koski RA: Cloning of cDNAs encoding human TIMP-3, a novel member of the tissue inhibitor of metalloproteinase family. Gene 141: 293-297, 1994.
25. Wick M, Burger C, Brusselbach S, Lucibello FC and Muller R: A novel member of human tissue inhibitor of metalloproteinases (TIMP) gene family is regulated during G1 progression, mitogenic stimulation, differentiation, and senescence. J Biol Chem 269: 18953-18960, 1994.
26. Yang TT and Hawkes SP: Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts. Proc Natl Acad Sci USA 89: 10676-10680, 1992.
27. Anand-Apte B, Bao L, Smith R, Iwata K, Olsen BR, Zetter B and Apte SS: A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth. Biochem Cell Biol 74: 853-862, 1996.
28. Smith MR, Kung H, Durum SK, Colburn NH and Sun Y: TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells. Cytokine 9: 770-780, 1997.
29. Baker AH, Zaltsman AB, George SJ and Newby AC: Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro, TIMP-3 promotes apoptosis. J Clin Invest 101: 1478-1487, 1998.
30. Su S, Dehnade F and Zafarullah M: Regulation of tissue inhibitor of metalloproteinases-3 gene expression by transforming growth factor-beta and dexamethasone in bovine and human articular chondrocytes. DNA Cell Biol 15: 1039-1048, 1996.